Inhibiting the Effects of Angiotensin on Cardiovascular Hypertrophy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
The smooth muscle cell in culture
Chamley-Campbell, J., Campbell, G. R., & Ross, R. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.1.1 · Cited by 1,553
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Urata, H., Kinoshita, A., Misono, K. S., Bumpus, F. M., & Husain, A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45712-2 · Cited by 880
Preliminary biochemical characterization of two angiotensin II receptor subtypes
Whitebread, S., Mele, M., Kamber, B., & de Gasparo, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92133-5 · Cited by 777
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Daemen, M. J., Lombardi, D. M., Bosman, F. T., & Schwartz, S. M. (1991) · Circulation Research · doi:10.1161/01.res.68.2.450 · Cited by 737
Naftilan, A. J., Pratt, R. E., & Dzau, V. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114032 · Cited by 623
Research works printed but not linked: 8
- Clowes AW, Reidy MA, Clowes MM: Kinetics of cellular proliferation after arterial injury. Lab Invest 49:327–334, 1983.
- Lyall F, Boswell F, Dornan ES, et al: Angiotensin II increases proto-oncogene expression and inositol phosphate levels through the AT1 receptor (abstract). J Hypertens 10(Suppl 4):S152, 1992.
- Sachinidis A, Ko Y, Görg A, et al: Losartan inhibits the angiotensin II (AII)-induced stimulation of the phosphoinositide (PI)-turnover and hypertrophy in vascular smooth muscle cells (abstract). J Hypertens 10(Suppl 4):S2, 1992.
- Brilla CG, Zhou G, Weber K: Angiotensin II and collagen synthesis in cultured adult rat cardiac fibroblasts (abstract). J Hypertens 10(Suppl 4):S125, 1992.
- Kannel WB, D’Agostino RB, Levy D, et al: Prognostic significance of regression of left ventricular hypertrophy. Circulation 78(Suppl 2):S89, 1988.
- Metsärinne KP, Stoll M, Gohlke P, et al: Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharm Pharmacol Lett 2:150–152, 1992.
- Camargo MJF, Campbell WG, Lutterotti N, et al: Chronic oral angiotensin II-blockade with losartan (DuP 753 or LOS) inhibits the development of hypertension and end-organ damage in stroke-prone spontaneously hypertensive rats (abstract). J Hypertens 10(Suppl 4):S190, 1992.
- Kromer EP, Schunkert H, Ackermann B, et al: Effects of angiotensin H1-receptor antagonism on pressure induced left ventricular hypertrophy (abstract). J Hypertens 10(Suppl 4):S252, 1992.
Cited by
Guo, D., Tardif, V., Ghelima, K., Chan, J. S. D., Ingelfinger, J. R., Chen, X.-M., & Chénier, I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401544200 · Cited by 32
Meloche, S., Pelletier, S. W., & Servant, M. J. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4351-0_12 · Cited by 11
Meloche, S., Pelletier, S. W., & Servant, M. J. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007140606333 · Cited by 10
“In vivo studies have shown that chronic infusion of Ang II leads to the development of vascular hypertrophy in rats, whereas administration of angiotensin-converting enzyme (ACE) inhibitors or Ang II receptor antagonists prevents or regresses vascular hypertrophy in models of genetic and experimental hypertension [4].”
BackgroundRécepteurs de l'angiotensine II
Chassagne, C., Servant, M. J., & Meloche, S. (1996) · médecine/sciences · doi:10.4267/10608/677 · Cited by 3
Humphrey, J. D. (2002) · Springer eBooks · doi:10.1007/978-0-387-21576-1_8 · Cited by 2
Metadata
- Authors
- Metsärinne, K. P., Stoll, M., Falkenhahn, M., Gohlke, P., & Unger, T.
- Affiliations
- Heidelberg University (DE)
- Venue
- Angiotensin Receptors
- Publisher
- Springer US
- Published
- 1994
- Pages
- 235-253
- OpenAlex
- W2203380186
- Semantic Scholar
- 85df74d66c3b2a91e4ae54735a35516cd3e181e5
- Cited by
- 6
- References
- 96
- FWCI
- 1.12
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Springer eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- angiotensin II, cardiovascular hypertrophy, vascular smooth muscle cell growth, hypertension, vasoconstriction, angiotensin receptor blockers, regression of hypertrophy, myocardial fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibiting the Effects of Angiotensin on Cardiovascular Hypertrophy. https://app.cochat.ai/papers/10.1007/978-1-4615-2464-9_13
- The paper
- Metsärinne, K. P., Stoll, M., Falkenhahn, M., Gohlke, P., & Unger, T. (1994). Inhibiting the Effects of Angiotensin on Cardiovascular Hypertrophy. Angiotensin Receptors. https://doi.org/10.1007/978-1-4615-2464-9_13
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.